Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
797,44 USD | -0,31 % | +3,86 % | +2,93 % |
20:09 | Branchen-Update: Aktien im Gesundheitswesen legen am Montagnachmittag zu | MT |
20:03 | Eli Lilly erwartet Zulassung für experimentelle Schlankheitspille bis Anfang 2026 | MT |
Zu einer Liste hinzufügen 0 ausgewählt | Umsatz (Y-1) | Nettomarge (Y-1) | Umsatzrendite (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Verbindlichkeiten / EBITDA) (Y-1) | |
---|---|---|---|---|---|---|---|
34 124 100 000,00 | +15,36% | +20,68% | 48.93x | 9.23x | 2.6x | ||
31 853 796 285,25 | +36,03% | +44,16% | 88.07x | 30.12x | -0.03x | ||
85 159 000 000,00 | +41,28% | +32,25% | 34.91x | 14.32x | 0.21x | ||
54 318 000 000,00 | +8,95% | +45,64% | 143.18x | 14.46x | 1.82x | ||
60 115 000 000,00 | +0,61% | +10,33% | 9.18x | 3.56x | 2.77x | ||
63 994 245 357,05 | +19,58% | +32,77% | 45.73x | 16.71x | 0.85x | ||
45 811 000 000,00 | +13,01% | +31,73% | 29.77x | 11.48x | 1.66x | ||
45 440 000 000,00 | +32,69% | +36,03% | 25.37x | 12.37x | 0.67x | ||
58 496 000 000,00 | +3,62% | +15,90% | 11.37x | 4.96x | 3.8x | ||
28 190 000 000,00 | +23,83% | +47,53% | 202.85x | 12.37x | 3.07x | ||
44 079 418 687,95 | +12,54% | +29,42% | 13.65x | 4.27x | 0.55x | ||
45 006 000 000,00 | +17,83% | +37,30% | 51.57x | 8.36x | 1.55x | ||
27 116 000 000,00 | +20,89% | +38,66% | 38.46x | 13.49x | 1.34x | ||
7 041 232 410,65 | +29,29% | +39,52% | 21.3x | 23.34x | -1.57x | ||
36 995 742 708,32 | +16,25% | +28,97% | 52.48x | 10.55x | 1.29x | ||
10 147 810 716,12 | +12,53% | +13,21% | 12.8x | 7.95x | -2.01x | ||
27 013 704 011,10 | +3,38% | +5,02% | 2.1x | 0.36x | 4.66x | ||
13 786 793 856,81 | +9,28% | +22,55% | 6.37x | 3.05x | 3.01x | ||
3 112 142 480,74 | +18,85% | +21,52% | 10.99x | 9.99x | -3.66x | ||
Durchschnitt | 37.989.472.974,42 | +17,67 % | +29,11 % | 44,69x | 11,10x | 1,19x | |
Gewichteter Durchschnitt nach Marktkapitalisierung | 45.359.262.062,72 | +19,63 % | +30,50 % | 55,14x | 12,80x | 1,48x |
- Börse
- Aktien
- 858560 Aktie
- Sektor Eli Lilly and Company
- Finanzielle Vergleiche
MarketScreener is also available in this country: United States.
Switch edition